Foods fortified with folic acid are associated with a decrease in infants being born with congenital heart defects.
Patients who experience nocturia, or frequent urination during the night, may have increased mortality rates.
The American Heart Association has published a scientific statement that outlines which medications cause or exacerbate heart failure.
At 16 months, 30.3% of patients either died or experienced worsening heart failure.
Specific patient characteristics predicted the type of therapy more likely to be prescribed.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.
Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.
Incident events were most common in those within the lowest tertile of basline ALT serum.
The FDA warns that the antidiarrheal loperamide can lead to serious cardiac events when taken in high doses.
Antiretroviral therapy in HIV-positive patients did not decrease the progression of arterial inflammation.
Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptivesJune 04, 2016
Compared with other estrogen doses and progestogen types, low-dose estrogen with levonorgestrel had a decreased risk of adverse events.
Addressing factors that lead to lack of adherence to antihypertensive therapy in elderly patients is crucial to improving outcomes.
Deferred defibrillation was not associated with improved survival.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patientsApril 20, 2016
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
Training the public in bystander CPR and first responder defibrillation improves outcomes for cardiac arrest that occurs outside of a hospital.
Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.
A large study found that use of SSRI medications to treat depression does not increase the risk of cardiovascular events in patients 20 to 64 years of age.
Electronic consultation between PCPs and specialists can resolve cases faster than if a patient followed up with a specialist themselves.
Women and men experience different symptoms, risks, and outcomes of myocardial infarction.
Patients who were obese and underwent bariatric surgery saw a significant reduction in heart failure-related exacerbation events.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Although pioglitazone decreased the risk of stroke and myocardial infarction in this population, it elevated the risk of weight gain, edema, and bone fracture.
A one-point increase in the American Heart Association's Life's Simple 7 checklist correlated to a 23% lower risk of developing heart failure.